COVID-19 illness and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB)."We know that patients with cardiovascular diseases are at particular risk of severe Covid-19 infection," said lead researcher Vassilios Vassiliou, from UEA's Norwich Medical School."But at the start of the pandemic, there was concern that specific medications for high blood pressure could be linked with worse outcomes for COVID-19 patients," Vassiliou said.The researchers, including those from Norfolk and Norwich University Hospital, analysed what the impact of these medications is for people with COVID-19.They studied the outcomes for patients taking.